Palladium-103 plaque radiation therapy for retinal angioma
<sup>103</sup>Pd plaque brachytherapy was utilized to treat two peripheral retinal vascular angiomas. Calculated doses to fovea and optic disc suggest no risk of radiation maculopathy or optic neuropathy. <sup>103</sup>Pd plaque brachytherapy was found to control tumor growth and reverse their exudation resulting in preservation of vision.
Authors
- A. Lukban
- Julie R. Bloom (ORCID: https://orcid.org/0000-0002-3819-7852)
- Paul T. Finger (ORCID: https://orcid.org/0000-0002-8111-3896)
- Robert D. Stewart
- Kenneth E. Rosenzweig
- Ren‐Dih Sheu (ORCID: https://orcid.org/0009-0006-2690-4835)
Institutions
- Tulane University (US)
- Mount Sinai Hospital (US)
- Eye Cancer Foundation (US)
Publication Details
- Journal
- American Journal of Ophthalmology Case Reports
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1016/j.ajoc.2025.102482
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00